PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Trial details
- Registry ID
- NCT00690066
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Prochymal; ex vivo cultured adult human mesenchymal stem cells
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)NCT00690066 | Mesoblast, Inc. | Phase 2 | Completed | 2010-12-12Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |